Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: A novel mechanism for cannabinoid-induced cell death

Cell Death and Disease

Volumn 4, Issue 12, 2013, Pages

  Rimmerman, N ^a   Ben Hail, D ^b   Porat, Z ^c   Juknat, A ^a   Kozela, E ^a   Daniels, M P ^d   Connelly, P S ^d   Leishman, E ^e   Bradshaw, H B ^e   Shoshan Barmatz, V ^b   Vogel, Z ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e INDIANA UNIVERSITY   (United States)

Author keywords

cancer; cannabidiol; cell death; microglia; mitochondria; voltage dependent anion channel 1

Indexed keywords

ANTINEOPLASTIC AGENT; CANNABIDIOL; CANNABINOID; VOLTAGE DEPENDENT ANION CHANNEL 1;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL DEATH; CELL ENERGY; CELL FRACTIONATION; CELL VIABILITY; DENSITY GRADIENT; HUMAN; MASS SPECTROMETRY; MEMBRANE CHANNEL; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CANNABIDIOL; CANNABINOIDS; CELL DEATH; CELL LINE; FLOW CYTOMETRY; MICE; MICROGLIA; VOLTAGE-DEPENDENT ANION CHANNEL 1;

EID: 84891802683     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.471     Document Type: Article

References (60)

1. Russo E, Guy GW. A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypothes 2006; 66: 234-246
2. Weiss L, Zeira M, Reich S, Slavin S, Raz I, Mechoulam R et al. Cannabidiol arrests onset of autoimmune diabetes in NOD mice. Neuropharmacology 2008; 54: 244-249
3. McAllister SD, Murase R, Christian RT, Lau D, Zielinski AJ, Allison J et al. Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Breast Cancer Res Treat 2011; 129: 37-47
4. Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R et al. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-Arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci USA 2000; 97: 9561-9566
5. Kozela E, Lev N, Kaushansky N, Eilam R, Rimmerman N, Levy R et al. Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice. Br J Pharmacol 2011; 163: 1507-1519
6. Moreira FA, Aguiar DC, Guimaraes FS. Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test. Progress Neuro-psychopharmacol Biol Psychiatr 2006; 30: 1466-1471
7. Rock EM, Bolognini D, Limebeer CL, Cascio MG, Anavi-Goffer S, Fletcher PJ et al. Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausealike behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus. Br J Pharmacol 2012; 165: 2620-2634
8. Fernandez-Ruiz J, Sagredo O, Pazos MR, Garcia C, Pertwee R, Mechoulam R et al. Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid? Br J Clin Pharmacol 2012; 75: 323-333
9. Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L et al. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther 2006; 318: 1375-1387
10. Leweke FM, Piomelli D, Pahlisch F, Muhl D, Gerth CW, Hoyer C et al. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatr 2012; 2: E94
11. Rimmerman N, Kozela E, Levy R, Vogel Z, Juknat A. Cannabinoid signaling through non-CB1, non-CB2 GPCR targets in microglia. In Abood ME, Sorensen RG, Stella N (eds) Actions at Non-CB1/CB2 Cannabinoid Receptors. Springer: New York, 2013. pp 143-171
12. Carrier EJ, Auchampach JA, Hillard CJ. Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression. Proc Natl Acad Sci USA 2006; 103: 7895-7900
13. De Petrocellis L, Ligresti A, Moriello AS, Allara M, Bisogno T, Petrosino S et al. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol 2011; 163: 1479-1494
14. O'Sullivan SE, Kendall DA. Cannabinoid activation of peroxisome proliferator-Activated receptors: Potential for modulation of inflammatory disease. Immunobiology 2010; 215: 611-616
15. Ryan D, Drysdale AJ, Lafourcade C, Pertwee RG, Platt B. Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels. J Neurosci 2009; 29: 2053-2063
16. Drysdale AJ, Ryan D, Pertwee RG, Platt B. Cannabidiol-induced intracellular Ca2+ elevations in hippocampal cells. Neuropharmacology 2006; 50: 621-631
17. Massi P, Vaccani A, Bianchessi S, Costa B, Macchi P, Parolaro D. The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells. Cell Mol Life Sci 2006; 63: 2057-2066
18. Castillo A, Tolon MR, Fernandez-Ruiz J, Romero J, Martinez-Orgado J. The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors. Neurobiol Dis 2010; 37: 434-440
19. Shrivastava A, Kuzontkoski PM, Groopman JE, Prasad A. Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-Talk between apoptosis and autophagy. Mol Cancer Ther 2011; 10: 1161-1172
20. Gallily R, Even-Chena T, Katzavian G, Lehmann D, Dagan A, Mechoulam R. Gamma-irradiation enhances apoptosis induced by cannabidiol, a non-psychotropic cannabinoid, in cultured HL-60 myeloblastic leukemia cells. Leuk Lymph 2003; 44: 1767-1773
21. Vaccani A, Massi P, Colombo A, Rubino T, Parolaro D. Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism. Br J Pharmacol 2005; 144: 1032-1036
22. McKallip RJ, Jia W, Schlomer J, Warren JW, Nagarkatti PS, Nagarkatti M. Cannabidiolinduced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression. Mol Pharmacol 2006; 70: 897-908
23. Lee CY, Wey SP, Liao MH, Hsu WL, Wu HY, Jan TR. A comparative study on cannabidiolinduced apoptosis in murine thymocytes and EL-4 thymoma cells. Int Immunopharmacol 2008; 8: 732-740
24. Wu HY, Chu RM, Wang CC, Lee CY, Lin SH, Jan TR. Cannabidiol-induced apoptosis in primary lymphocytes is associated with oxidative stress-dependent activation of caspase-8. Toxicol Appl Pharmacol 2008; 226: 260-270
25. Wu HY, Chang AC, Wang CC, Kuo FH, Lee CY, Liu DZ et al. Cannabidiol induced a contrasting pro-Apoptotic effect between freshly isolated and precultured human monocytes. Toxicol Appl Pharmacol 2010; 246: 141-147
26. Raz A, Goldman R. Effect of hashish compounds on mouse peritoneal macrophages. Lab Invest 1976; 34: 69-76
27. Rimmerman N, Juknat A, Kozela E, Levy R, Bradshaw HB, Vogel Z. The non-psychoactive plant cannabinoid, cannabidiol affects cholesterol metabolism-related genes in microglial cells. Cell Mol Neurobiol 2011; 31: 921-930
28. Wu HY, Goble K, Mecha M, Wang CC, Huang CH, Guaza C et al. Cannabidiol-induced apoptosis in murine microglial cells through lipid raft. Glia 2012; 60: 1182-1190
29. Kozela E, Pietr M, Juknat A, Rimmerman N, Levy R, Vogel Z. Cannabinoids Delta(9)-Tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-Activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells. J Biol Chem 2010; 285: 1616-1626
30. Juknat A, Pietr M, Kozela E, Rimmerman N, Levy R, Coppola G et al. Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Delta9-Tetrahydrocannabinol in BV-2 microglial cells. Br J Pharmacol 2012; 165: 2512-2528
31. Juknat A, Rimmerman N, Levy R, Vogel Z, Kozela E. Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells. Neurochem Int 2012; 61: 923-930
32. Juknat A, Pietr M, Kozela E, Rimmerman N, Levy R, Gao F et al. Microarry and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPSinduced activation of BV-2 microglial cells. Plos One 2013; 10: 1371
33. Rimmerman N, Bradshaw HB, Kozela E, Levy R, Juknat A, Vogel Z. Compartmentalization of endocannabinoids into lipid rafts in a microglial cell line devoid of caveolin-1. Br J Pharmacol 2012; 165: 2436-2449
34. Shoshan-Barmatz V, Ben-Hail D. VDAC, a multi-functional mitochondrial protein as a pharmacological target. Mitochondrion 2011; 12: 24-34
35. Shoshan-Barmatz V, De Pinto V, Zweckstetter M, Raviv Z, Keinan N, Arbel N. VDAC, a multi-functional mitochondrial protein regulating cell life and death. Mol Aspect Med 2010; 31: 227-285
36. Shoshan-Barmatz V, Mizrachi D. VDAC1: From structure to cancer therapy. Front Oncol 2012; 2: 164 PMID 20471992
37. Ramer R, Heinemann K, Merkord J, Rohde H, Salamon A, Linnebacher M et al. COX-2 and PPAR-gamma confer cannabidiol-induced apoptosis of human lung cancer cells. Mol Cancer Ther 2012; 12: 69-82
38. Ribeiro A, Ferraz-de-Paula V, Pinheiro ML, Vitoretti LB, Mariano-Souza DP, Quinteiro-Filho WM et al. Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A(2A) receptor. Eur J Pharmacol 2012; 678: 78-85
39. Mato S, Victoria Sanchez-Gomez M, Matute C. Cannabidiol induces intracellular calcium elevation and cytotoxicity in oligodendrocytes. Glia 2010; 58: 1739-1747
40. Wieckowski MR, Giorgi C, Lebiedzinska M, Duszynski J, Pinton P. Isolation of mitochondria-Associated membranes and mitochondria from animal tissues and cells. Nat Protoc 2009; 4: 1582-1590
41. Macdonald JL, Pike LJ. A simplified method for the preparation of detergent-free lipid rafts. J Lipid Res 2005; 46: 1061-1067
42. Rimmerman N, Hughes HV, Bradshaw HB, Pazos MX, Mackie K, Prieto AL et al. Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line. Br J Pharmacol 2008; 153: 380-389
43. Siemen D, Ziemer M. What is the nature of the mitochondrial permeability transition pore and what is it not? IUBMB Life 2013; 65: 255-262
44. Shoshan-Barmatz V, Gincel D. The voltage-dependent anion channel: Characterization, modulation, and role in mitochondrial function in cell life and death. Cell Biochem Biophys 2003; 39: 279-292
45. Tsujimoto Y, Shimizu S. Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 2007; 12: 835-840
46. Vander Heiden MG, Chandel NS, Li XX, Schumacker PT, Colombini M, Thompson CB. Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival. Proc Natl Acad Sci USA 2000; 97: 4666-4671
47. Abu-Hamad S, Sivan S, Shoshan-Barmatz V. The expression level of the voltagedependent anion channel controls life and death of the cell. Proc Natl Acad Sci USA 2006; 103: 5787-5792
48. Popp B, Schmid A, Benz R. Role of sterols in the functional reconstitution of water-soluble mitochondrial porins from different organisms. Biochemistry 1995; 34: 3352-3361
49. Hiller S, Garces RG, Malia TJ, Orekhov VY, Colombini M, Wagner G. Solution structure of the integral human membrane protein VDAC-1 in detergent micelles. Science 2008; 321: 1206-1210
50. Campbell AM, Chan SH. Mitochondrial membrane cholesterol, the voltage dependent anion channel (VDAC), and the Warburg effect. J Bioenerget Biomem 2008; 40: 193-197
51. Rone MB, Midzak AS, Issop L, Rammouz G, Jagannathan S, Fan J et al. Identification of a dynamic mitochondrial protein complex driving cholesterol import, trafficking, and metabolism to steroid hormones. Mol Endocrinol 2009; 26: 1868-1882
52. Gincel D, Zaid H, Shoshan-Barmatz V. Calcium binding and translocation by the voltage-dependent anion channel: A possible regulatory mechanism in mitochondrial function. Biochem J 2001; 358: 147-155
53. Rapizzi E, Pinton P, Szabadkai G, Wieckowski MR, Vandecasteele G, Baird G et al. Recombinant expression of the voltage-dependent anion channel enhances the transfer of Ca2+ microdomains to mitochondria. J Cell Biol 2002; 159: 613-624
54. Tan W, Colombini M. VDAC closure increases calcium ion flux. Biochim Biophys Acta 2007; 1768: 2510-2515
55. Zaid H, Abu-Hamad S, Israelson A, Nathan I, Shoshan-Barmatz V. The voltage-dependent anion channel-1 modulates apoptotic cell death. Cell Death Differ 2005; 12: 751-760
56. Saba R, Gushue S, Huzarewich RL, Manguiat K, Medina S, Robertson C et al. MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state. PloS One 2012; 7: E30832
57. Massi P, Vaccani A, Ceruti S, Colombo A, Abbracchio MP, Parolaro D. Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines. J Pharmacol Exp Ther 2004; 308: 838-845
58. George TC, Fanning SL, Fitzgerald-Bocarsly P, Medeiros RB, Highfill S, Shimizu Y et al. Quantitative measurement of nuclear translocation events using similarity analysis of multispectral cellular images obtained in flow. J Immunol Methods 2006; 311: 117-129
59. Arbel N, Ben-Hail D, Shoshan-Barmatz V. Mediation of the antiapoptotic activity of Bcl-xL protein upon interaction with VDAC1 protein. J Biol Chem 2012; 287: 23152-23161
60. Wienken CJ, Baaske P, Rothbauer U, Braun D, Duhr S. Protein-binding assays in biological liquids using microscale thermophoresis. Nat Commun 2010; 1: 100